Accelovance Prepares for Continued Growth; Adds to Senior Management Team
ROCKVILLE, Md., Feb. 16 /PRNewswire-USNewswire/ -- Accelovance, a CRO with a proven approach to reduce timelines and optimize productivity, announced today two additions to its senior management team; Joseph W. Angle, Jr. has been appointed Chief Financial Officer and Lisa Beth Ferstenberg, MD has been appointed Chief Medical Officer (CMO). These additions come after another 12-month period of continued growth for Accelovance and recent recognition as "Best CRO" vaccine industry excellence award winner.
Mr. Angle will lead the financial and administrative functions at Accelovance after serving as interim CFO for the last six months. He has recently been a consulting CFO to several Washington, DC-area companies, Mr. Angle has over 15 years of experience in the drug development industry. He previously co-founded several companies with Accelovance CEO, Stephen J. Trevisan, including TherImmune Research Corporation, CommSys Corporation and National Clinical Research Centers (NCRC). Mr. Angle helped manage each company to profitability and year-after-year double digit revenue growth.
Headquartered in Rockville, Maryland, Accelovance is a privately held company that has developed a unique operational approach for delivering quality, on time, and cost effective clinical studies. The company was recognized as "2009's Best CRO" with an Industry Excellence award. Accelovance offers six (6) wholly-owned, research-dedicated clinical sites to Sponsors and CROs that bring greater control, predictability, and quality assurance to vaccine programs. Additionally, the Company tailors its offering of full CRO, Clinical Sites, Patient Recruitment, and Call Center to present a clinical solution that meets a Sponsor's needs. Accelovance has a 100% owned subsidiary providing CRO services in China. These capabilities can assist clients with global development programs or product registration in China, the fastest growing pharmaceutical market in the world.
CONTACT: Garrett D. Smith of Accelovance, +1-240-238-4914,
gsmith@accelovance.com
Web site: http://www.accelovance.com/